Company & Sponsor Intelligence

Holland Bloorview Kids Rehabilitation Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting0

Completed6

Countries2

Therapeutic footprint

autism

Indexed studies

NCT05235919Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder
autism · CanadaPHASE2

NCT01908205Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
autism · United StatesPHASE2

NCT03887676Arbaclofen vs. Placebo in the Treatment of Children and Adolescents With ASD (ARBA)
autism · CanadaPHASE2

NCT01661855A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD
autism · CanadaPHASE2

NCT02160691Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder
autism · CanadaNA

NCT03992118Project LEaH: Learning to Eat at Home
autism · CanadaNA

NCT03499262Group Social ABCs: Early Intervention for Toddlers With Suspected ASD
autism · CanadaNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →